954 — Changmao Biochemical Engineering Co Income Statement
0.000.00%
Last trade - 00:00
- HK$222.47m
- HK$653.49m
- CNY637.08m
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 495 | 444 | 548 | 730 | 637 |
Cost of Revenue | |||||
Gross Profit | 135 | 95.4 | 38.7 | 181 | 25.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 432 | 427 | 462 | 641 | 689 |
Operating Profit | 62.8 | 17 | 85.8 | 89.4 | -52 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 62.6 | 17.2 | 84.4 | 87.6 | -58.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 57.9 | 16.7 | 58.2 | 81.4 | -86.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 58.3 | 16.8 | 58.3 | 81.4 | -86.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 58.3 | 16.8 | 58.3 | 81.4 | -86.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.113 | 0.058 | -0.007 | 0.177 | -0.156 |
Dividends per Share |